TapewireFind a company

person · Reporting owner

Watkins Jonathan

Disclosed activity across 1 company

Tapewire entity
79189
SEC CIK
0002058845

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
SmartKem, Inc.SMTK · Entity 8554Chief Operating OfficerMay 28, 2025May 28, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

SmartKem, Inc.

Report date May 28, 2025 · Filed May 28, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.51 · Expires 2035-04-15Direct131,745 Reported balance After 2025-05-28 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-05-28 · Grant · Acquired 131,745 · Balance 131,745

F1: The stock option grant was approved by the Compensation Committee of SmartKem, Inc.'s (the "Company") board of directors on April 15, 2025, subject to stockholder approval of an Amendment to the SmartKem, Inc. 2021 Equity Incentive Plan (the "Amendment"). The Company's stockholders approved the Amendment on May 28, 2025.

F2: The option vests as follows: 25% on the date of grant with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on May 15, 2025 and on the 15th date of each month thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: The stock option grant was approved by the Compensation Committee of SmartKem, Inc.'s (the "Company") board of directors on April 15, 2025, subject to stockholder approval of an Amendment to the SmartKem, Inc. 2021 Equity Incentive Plan (the "Amendment"). The Company's stockholders approved the Amendment on May 28, 2025.

F2: The option vests as follows: 25% on the date of grant with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on May 15, 2025 and on the 15th date of each month thereafter.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 28, 2025 Filed May 28, 2025 21:00 UTC SmartKem, Inc. SMTK · Entity 8554 GrantStock Option (right to Buy) · Derivative 131,745 $0.00 Strike: $2.51 $0.00
Disclosure

SEC source: 0001641172-25-012768 · ownership.xml · derivative · entry 1

Watkins Jonathan · CIK 0002058845 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,745

Underlying: Common Stock · 131,745 shares

Expires 2035-04-15

F1 · date: The stock option grant was approved by the Compensation Committee of SmartKem, Inc.'s (the "Company") board of directors on April 15, 2025, subject to stockholder approval of an Amendment to the SmartKem, Inc. 2021 Equity Incentive Plan (the "Amendment"). The Company's stockholders approved the Amendment on May 28, 2025.

F2 · derivative.exercise_date: The option vests as follows: 25% on the date of grant with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on May 15, 2025 and on the 15th date of each month thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.